Lysoway Therapeutics, a clinical-stage biotechnology company pioneering therapeutics targeting lysosomal ion channels for age ...

Looks as though a new Cambridge startup in the space of antibody drug development is revving up to make a big splash. The company was founded in 2013 as the Kairos Biologics Foundation, but changed ...

Ride Therapeutics, a transatlantic life science spin-out from the Universities of Cambridge in the UK and Harvard in the US, ...

LONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners ...

President and CEO Sanjeev Luther to present on Wednesday, September 16, 2026, at 12:00 p.m. ET Management available for ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

Shionogi has announced its participation in the Cambridge Therapeutics Consortium, bringing its expertise in small molecules to help develop novel therapies through the open innovation model. The ...

A new darling of the drug industry could be heading to Cambridge Crossing. Sage’s upcoming expansion comes after Tuesday’s U.S. Food and Drug Administration approval of Zulresso, Sage’s drug to treat ...